Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
Akebia Therapeutics (AKBA) Ownership - Who Owns Akebia Therapeutics?
1,202 Followers
Akebia Therapeutics (AKBA) Ownership Overview
5.55% Insiders
8.59% Mutual Funds
4.50% Other Institutional Investors
81.36% Public Companies and Individual Investors
The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail and individual investors. Approximately 13.10% of the company’s stock is owned by Institutional Investors, 5.55% is owned by Insiders and 81.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 01, 2024 | Nicole Hadas Svp, Clo | Sold | $9439 |
| Mar 01, 2024 | Michel Dahan Svp, Coo | Sold | $13684 |
| Mar 01, 2024 | John P. Butler Ceo & President,director | Sold | $73581 |
| Mar 01, 2024 | Steven Keith Burke Svp, Chief Medical Officer | Sold | $11327 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $29304 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,939,047 | Institution | 3.79% | 10,876,494 | |
| 7,312,341 | Institution | 3.49% | 10,017,907 | |
| 4,698,164 | Institution | 2.24% | 6,436,485 | |
| 2,364,436 | Insider | 1.13% | 3,239,277 | |
| 2,061,572 | Institution | 0.98% | 2,824,354 | |
| 2,002,560 | Insider | 0.96% | 2,743,507 | |
| 1,625,838 | Institution | 0.78% | 2,227,398 | |
| 809,713 | Institution | 0.39% | 1,109,307 | |
| 663,259 | Insider | 0.32% | 908,665 | |
| 492,750 | Institution | 0.24% | 675,068 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,312,341 | Institution | 3.49% | 10,017,907 | |
| 4,698,164 | Institution | 2.24% | 6,436,485 | |
| 2,061,572 | Institution | 0.98% | 2,824,354 | |
| 1,625,838 | Institution | 0.78% | 2,227,398 | |
| 809,713 | Institution | 0.39% | 1,109,307 | |
| 492,750 | Institution | 0.24% | 675,068 | |
| 396,648 | Institution | 0.19% | 543,408 | |
| 145,207 | Institution | 0.07% | 198,934 | |
| 119,228 | Institution | 0.06% | 163,342 | |
| 115,906 | Institution | 0.06% | 158,791 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,336,188 | Institution | 2.55% | 9,765,224 | |
| 2,602,859 | Institution | 1.24% | 4,763,232 | |
| 290,501 | Institution | 0.14% | 395,081 | |
| 25,835 | Institution | 0.01% | 35,136 |
FAQ
Who Owns Akebia Therapeutics (AKBA)?
According to the latest TipRanks data, approximately 4.50% of the company's stock is held by institutional investors, 5.55% is held by insiders, and 81.36% is held by retail investors.
What percentage of Akebia Therapeutics (AKBA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.50% of Akebia Therapeutics (AKBA) stock is held by institutional investors.
What percentage of Akebia Therapeutics (AKBA) stock is held by retail investors?
According to the latest TipRanks data, approximately 81.36% of Akebia Therapeutics (AKBA) stock is held by retail investors.
Who owns the most shares of Akebia Therapeutics (AKBA)?
Vanguard owns the most shares of Akebia Therapeutics (AKBA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.